A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based

Clinical trial NCT01820572 · COMPLETED

Trial details

NCT number: NCT01820572
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Kidney Transplantation

Start date: 2013-03-27
Primary completion: 2019-10-24
Enrollment: 446

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.